CITED4 Antikörper (full length, N-Term)
-
- Target Alle CITED4 Antikörper anzeigen
- CITED4 (Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 4 (CITED4))
-
Bindungsspezifität
- full length, N-Term
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser CITED4 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunoprecipitation (IP)
- Spezifität
- Reacts with human CITED4 protein
- Kreuzreaktivität
- Maus
- Kreuzreaktivität (Details)
- Does not work well on mouse. Not tested in other species .
- Aufreinigung
- Purified
- Immunogen
- N-terminal fusion protein to full-length human CITED4
- Klon
- HT13-2D6-3
- Isotyp
- IgG1 kappa
- Top Product
- Discover our top product CITED4 Primärantikörper
-
-
- Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- ELISA : 1/100 to 1/1 000 - IF : 1/100 to 1/1 000 - IP : 1/100 to 1/1 000 - WB : 1/100 to 1/1 000 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- Tris-glycine, NaCl 150 mM buffer, Sodium azide 0.05 %
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C/-80 °C
- Informationen zur Lagerung
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
- Target
- CITED4 (Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 4 (CITED4))
- Andere Bezeichnung
- Cbp/p300-Interacting Transactivator 4 (CITED4 Produkte)
- Synonyme
- CITED4 antikoerper, MRG-2 antikoerper, Mrg2 antikoerper, CITED3 antikoerper, cCITED3 antikoerper, similar to Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal antikoerper, Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 4 antikoerper, Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 4 antikoerper, Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 4 L homeolog antikoerper, Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 antikoerper, CITED4 antikoerper, cited4 antikoerper, cited4.L antikoerper, Cited4 antikoerper
-